Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 5
2005 6
2006 4
2007 4
2008 5
2009 3
2010 2
2011 1
2012 3
2013 6
2014 7
2015 8
2016 3
2017 7
2019 4
2020 3
2021 4
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum: Editorial: Metabolic modulation of cellular function.
Kakhlon O, Saada A, Escriba PV. Kakhlon O, et al. Among authors: escriba pv. Front Cell Dev Biol. 2024 Apr 11;12:1403128. doi: 10.3389/fcell.2024.1403128. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38665431 Free PMC article.
Editorial: Metabolic modulation of cellular function.
Kakhlon O, Saada A, Escriba PV. Kakhlon O, et al. Among authors: escriba pv. Front Cell Dev Biol. 2024 Mar 18;12:1395922. doi: 10.3389/fcell.2024.1395922. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38562142 Free PMC article. No abstract available.
Antimicrobial activity, membrane interaction and structural features of short arginine-rich antimicrobial peptides.
Agrillo B, Porritiello A, Gratino L, Balestrieri M, Proroga YT, Mancusi A, Cozzi L, Vicenza T, Dardano P, Miranda B, Escribá PV, Gogliettino M, Palmieri G. Agrillo B, et al. Among authors: escriba pv. Front Microbiol. 2023 Oct 5;14:1244325. doi: 10.3389/fmicb.2023.1244325. eCollection 2023. Front Microbiol. 2023. PMID: 37869668 Free PMC article.
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D, Fernández-García P, Lladó V, McNicholl AG, Rosselló CA, Taylor RJ, Azaro A, Rodón J, Sludden J, Veal GJ, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escribá PV. Lopez J, et al. Among authors: escriba pv. Br J Cancer. 2023 Sep;129(5):811-818. doi: 10.1038/s41416-023-02356-1. Epub 2023 Jul 24. Br J Cancer. 2023. PMID: 37488446 Free PMC article. Clinical Trial.
Multifaceted Analyses of Isolated Mitochondria Establish the Anticancer Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation and an Activator of Complex IV-Dependent State 3 Respiration.
Mishra K, Péter M, Nardiello AM, Keller G, Llado V, Fernandez-Garcia P, Kahlert UD, Barasch D, Saada A, Török Z, Balogh G, Escriba PV, Piotto S, Kakhlon O. Mishra K, et al. Among authors: escriba pv. Cells. 2022 Feb 7;11(3):578. doi: 10.3390/cells11030578. Cells. 2022. PMID: 35159387 Free PMC article.
80 results